Your browser doesn't support javascript.
loading
The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity.
García-Caballero, Agustin; Gadotti, Vinicius M; Stemkowski, Patrick; Weiss, Norbert; Souza, Ivana A; Hodgkinson, Victoria; Bladen, Chris; Chen, Lina; Hamid, Jawed; Pizzoccaro, Anne; Deage, Mickael; François, Amaury; Bourinet, Emmanuel; Zamponi, Gerald W.
Affiliation
  • García-Caballero A; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Gadotti VM; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Stemkowski P; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Weiss N; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Souza IA; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Hodgkinson V; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Bladen C; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Chen L; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Hamid J; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Pizzoccaro A; Laboratories of Excellence in Ion Channel Science and Therapeutics, Institut de Génomique Fonctionnelle, CNRS UMR5203, INSERM U661, IFR3 Universités Montpellier I&II, Montpellier, France.
  • Deage M; Laboratories of Excellence in Ion Channel Science and Therapeutics, Institut de Génomique Fonctionnelle, CNRS UMR5203, INSERM U661, IFR3 Universités Montpellier I&II, Montpellier, France.
  • François A; Laboratories of Excellence in Ion Channel Science and Therapeutics, Institut de Génomique Fonctionnelle, CNRS UMR5203, INSERM U661, IFR3 Universités Montpellier I&II, Montpellier, France.
  • Bourinet E; Laboratories of Excellence in Ion Channel Science and Therapeutics, Institut de Génomique Fonctionnelle, CNRS UMR5203, INSERM U661, IFR3 Universités Montpellier I&II, Montpellier, France.
  • Zamponi GW; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address: Zamponi@ucalgary.ca.
Neuron ; 83(5): 1144-58, 2014 Sep 03.
Article in En | MEDLINE | ID: mdl-25189210
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Endopeptidases / Calcium Channels, T-Type / Inflammation / Neuralgia Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Neuron Year: 2014 Type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Endopeptidases / Calcium Channels, T-Type / Inflammation / Neuralgia Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Neuron Year: 2014 Type: Article Affiliation country: Canada